Brief: Universal Biosensors Says Xprecia Prime 4U Approved For Patient Self-Testing In Europe
04/10/2023 02:19
Oct 4 (Reuters) - Universal Biosensors Inc UBI.AX :
* XPRECIA PRIME 4U APPROVED FOR PATIENT SELF-TESTING IN
EUROPE
Source text for Eikon: ID:nASX8pSqzj
Further company coverage: UBI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Universal Biosensors
See all newsBrief: Universal Biosensors Seeks Trading Halt Pending Announcement On Financial Position & Funding
Brief: Universal Biosensors Signs Non-Binding Term Sheet For A$8.5M Funding
Brief: Universal Biosensors Seeks Trading Halt
Brief: Universal Biosensors Inc Posts Qtrly Total Revenue A$1.6 Million
Brief: Universal Biosensors Says John Sharman Steps Down As Managing Director And CEO